Baysal
Akif Baysal, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20140065656 | SPECIMEN IMAGING DEVICE AND METHODS FOR USE THEREOF - A specimen holding and positioning apparatus operable to substantially non-movably maintain a specimen (e.g., an excised tissue specimen) in a fixed or stable orientation with respect to the apparatus during imaging operations (e.g., x-ray imaging), transport (e.g., from a surgery room to a pathologist's laboratory), and the like for use in facilitating accurate detection and diagnosis of cancers and/or other abnormalities of the specimen. | 03-06-2014 |
Evren Baysal, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20150332403 | Calculating Liquidity Margin Requirements - Systems and methods are provided for calculating margin requirements and stress testing exposures of cleared credit portfolios. These margin requirements are calculated using the following components: spread risk, idiosyncratic risk, interest rate, and liquidity risk. The calculation of these risk components is accomplished with a detailed statistical analysis of the risk factors underlying instruments, such as a credit default swap instrument. | 11-19-2015 |
20150332404 | MARGIN REQUIREMENT DETERMINATION AND MODELING FOR CLEARED CREDIT - Systems and methods are provided for calculating margin requirements and stress testing exposures of cleared credit portfolios. These margin requirements are calculated using the following components: spread risk, idiosyncratic risk, interest rate, and liquidity risk. The calculation of these risk components is accomplished with a detailed statistical analysis of the risk factors underlying instruments, such as a credit default swap instrument. | 11-19-2015 |
Kemal Baysal, Gebze TR
Patent application number | Description | Published |
---|---|---|
20140199301 | RECOMBINANT ANTIBODY STRUCTURES BINDING TO AND BLOCKING THE ACTIVITY OF VASCULAR ENDOTHELIAL GROWTH FACTOR 2 (VEGFR- 2/KDR) - Phage displayed recombinant antibody library was developed and the library was screened against VEGFR-2. After screening and ELISA experiments two recombinant antibodies showing binding properties to VEGFR-2 was obtained. The difference of the two recombinant antibodies to the recombinant antibodies already developed was demonstrated by DNA sequence analysis. The inhibition effect of the two recombinant antibodies on endothelial cell proliferation was demonstrated with cell assays. Thus these recombinant antibodies might be used as VEGF related angiogenesis inhibitors. | 07-17-2014 |
Rafet Evren Baysal, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20140081820 | METHODS AND SYSTEMS FOR INTER-ACCOUNT MARGIN OPTIMIZATION - The disclosed embodiments relate to reducing, minimizing or otherwise optimizing margin requirements for a trader having both an interest rate (IR) futures and over-the-counter (OTC) interest rate swaps (IRS) accounts by efficiently allocating IR futures across both accounts. | 03-20-2014 |
Tuelin Baysal, Ludwigsburg DE
Patent application number | Description | Published |
---|---|---|
20160103450 | Fail-Safe EE Architecture for Automated Driving - A system with a first computer unit and with a second computer unit, wherein the first computer unit comprises a first interface to enable connection to at least one sensor and to at least one actuator, wherein the second computer unit comprises a second interface to enable connection to at least one sensor and to at least one actuator, wherein the first and the second computer units can be connected to each other by means of a further interface, wherein the actuator comprises an interface, wherein depending on the first or on the second operating state the interface determines whether a control command for a driving function is adopted by the first or the second computer unit, so that in the first operating state only the first computer unit can activate the actuator and in a second operating state only the second computer unit can activate the actuator. | 04-14-2016 |